Urology News and Research

Latest Urology News and Research

Sex therapy for prostate cancer after treatment may improve sex life: Study

Prostate cancer treatments can play havoc with men’s sex lives causing erectile dysfunction and other frustrating problems. For example, a recent study found about 60 percent of men with prostate cancer who had their prostate glands removed had not recovered their sexual function two years after their treatment. Many also lost some desire for sex and had a diminished ability to reach or enjoy orgasms. But new research shows that sex therapy can make a big difference.

27 Sep 2011

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Ipsen announces today a partnership with Photocure, a specialty pharmaceutical company focused on photodynamic technologies in cancer and dermatology.

27 Sep 2011

Men over 75 with prostate cancer are being undertreated: Study

It's an ongoing debate: Should men over a certain age be treated for prostate cancer? Should these patients be submitted to treatments that may result in significant side effects if they may not live very much longer?

27 Sep 2011

VUMC announces partnership with NorthCrest, Maury Regional and Williamson Medical Center

Leaders of Vanderbilt University Medical Center, Maury Regional Medical Center, Northcrest Medical Center and Williamson Medical Center today announced affiliation agreements establishing a partnership between these medical centers to work collaboratively to create new jointly operated programs and services in the counties where these hospitals reside.

26 Sep 2011

Complications requiring hospitalization after prostate biopsy rise: Study

In a study of complication rates following prostate biopsy among Medicare beneficiaries, Johns Hopkins researchers have found a significant rise in serious complications requiring hospitalization.

23 Sep 2011

Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection

Watson Pharmaceuticals, Inc. today confirmed that Momenta Pharmaceuticals, Inc. and Sandoz Inc. have filed suit against Amphastar Pharmaceuticals, Inc. and Watson on September 21, 2011 in the United States District Court for the District of Massachusetts.

23 Sep 2011

Woman with two wombs gives birth to miracle twins

A Florida woman with a rare medical condition has delivered twins -- one from each of her two uteruses. The 24-year-old mother, Andreea Barbosa and her husband, Miguel, conceived the twins without reproductive medicine. Nathan and Natalie Barbosa were born Sept. 15 at Morton Plant Hospital in Clearwater. They join 2-year-old sister, Izabella.

21 Sep 2011

Impotence after prostate cancer treatment

According to researchers patients undergoing treatment for prostate cancer could be at a risk of impotence. According to the new study, published in the Journal of the American Medical Association there may be a formula to help gauge those risks for three common types of treatment, including surgery and radiation.

21 Sep 2011

African-American men living in low sunlight areas more likely to have Vitamin D deficiency

African-American men living in areas with low sunlight are up to 3 - times more likely to have Vitamin D deficiency than Caucasian men and should take high levels of Vitamin D supplements, according to a new study from Northwestern University Feinberg School of Medicine.

21 Sep 2011

ERWW PR forms Health Buzz Group

Euro RSCG Worldwide PR (ERWW PR) announces the formation of its Health Buzz Group, a global division created in response to growing client interest in big, splashy “wows” from small budgets in quick time frames using traditional and social media to generate momentum.

20 Sep 2011

NYU Langone creates new Joan H. Tisch Center for Women's Health in New York City

NYU Langone Medical Center announced the establishment of its new Joan H. Tisch Center for Women's Health on the Upper East Side of Manhattan in New York City.

20 Sep 2011

FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection

Watson Pharmaceuticals, Inc. today announced that Amphastar Pharmaceuticals, Inc., has received U.S. Food and Drug Administration approval of its Abbreviated New Drug Application (ANDA) for Enoxaparin Sodium Injection in the 100mg/mL and 150mg/mL strengths.

20 Sep 2011

Good absorption of calcium linked to prostate cancer

A study by epidemiologists at Wake Forest Baptist Medical Center and colleagues suggests that a high intake of calcium causes prostate cancer among African-American men who are genetically good absorbers of the mineral.

17 Sep 2011

Pfizer awards 2011 fellowship to UH Case Medical Center for pain medicine and epilepsy

University Hospitals (UH) Case Medical Center's Division of Pain Medicine in the Department of Anesthesiology and the Epilepsy Center in the UH Neurological Institute have each received 2011 Medical & Academic Partnerships Fellowship Awards from Pfizer Inc.

15 Sep 2011

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Boston Scientific Corporation today issued the following statement from John Pedersen, Senior Vice President and President of the Company's Urology and Women's Health Division, following the conclusion of a two-day meeting of the U.S. Food and Drug Administration (FDA) Obstetrics & Gynecology Devices Advisory Committee.

12 Sep 2011

Studies examine overuse of scans in determining status of prostate cancer

During Prostate Cancer Awareness Month, researchers will publish the findings of two studies examining the use, or overuse, of scans in determining the status or level of a patient's prostate cancer after diagnosis. "Typically, patients with an elevated PSA level undergo a prostate biopsy to confirm the presence of cancer.

8 Sep 2011

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

OncoGenex Pharmaceuticals, Inc. announced today that data from two studies, a Phase II clinical study and a pre-clinical study, evaluating the investigational compound custirsen, were published in the September issues of the journals Clinical Cancer Research and Cancer Research.

7 Sep 2011

Urology News and Research

Latest Urology News and Research

Sex therapy for prostate cancer after treatment may improve sex life: Study

Photocure, Ipsen partner to commercialise Hexvix for diagnosis of bladder cancer

Men over 75 with prostate cancer are being undertreated: Study

VUMC announces partnership with NorthCrest, Maury Regional and Williamson Medical Center

Complications requiring hospitalization after prostate biopsy rise: Study

Momenta, Sandoz file patent suit against Amphastar and Watson over Enoxaparin Sodium Injection

Woman with two wombs gives birth to miracle twins

Impotence after prostate cancer treatment

African-American men living in low sunlight areas more likely to have Vitamin D deficiency

ERWW PR forms Health Buzz Group

NYU Langone creates new Joan H. Tisch Center for Women's Health in New York City

FDA approves Amphastar's ANDA for Enoxaparin Sodium Injection

Good absorption of calcium linked to prostate cancer

Pfizer awards 2011 fellowship to UH Case Medical Center for pain medicine and epilepsy

Boston Scientific releases statement on safety, effectiveness of surgical mesh for POP and SUI

Studies examine overuse of scans in determining status of prostate cancer

Leading cancer journals publish OncoGenex's custirsen pre-clinical and Phase II study data

Pathology Visions Conference to be held at Manchester Grand Hyatt in San Diego

Prostate cancer linked to pesticides: Study

Health Canada approves Bayer's STAXYN for treatment of erectile dysfunction

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Urology News and Research

Latest Urology News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in